Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.21.1
Consolidated Balance Sheets - USD ($)
Mar. 31, 2021
Dec. 31, 2020
Current Assets:    
Cash and cash equivalents $ 27,555,000 $ 5,297,000
Prepaid expenses 88,000 364,000
Total current assets 27,643,000 5,661,000
Current Liabilities:    
Accounts payable 2,377,000 2,243,000
Accrued expenses 856,000 1,296,000
Accrued interest 0 4,838,000
Convertible notes payable (net of discount of $4,519,000 at December 31, 2020) 0 26,303,000
Line of credit 31,000 31,000
Derivative liability 362,000 383,000
Total current liabilities 3,626,000 35,094,000
Stockholders' Deficit:    
Common stock, par value $0.001, 2,000,000,000 shares authorized, 20,517,431 and 5,218,122 shares issued and outstanding as of March 31, 2021 and December 31, 2020, respectively 21,000 5,000
Common stock issuable 25,956,000 0
Additional paid-in capital 623,287,000 566,356,000
Accumulated deficit (625,079,000) (595,628,000)
Noncontrolling interest (169,000) (169,000)
Total stockholders' deficit 24,017,000 (29,433,000)
Total liabilities and stockholders' deficit 27,643,000 5,661,000
Series C    
Stockholders' Deficit:    
Convertible preferred stock 1,000 1,000
Series J    
Stockholders' Deficit:    
Convertible preferred stock 0 2,000
Series K    
Stockholders' Deficit:    
Convertible preferred stock $ 0 $ 0